• Syros Pharmaceuticals (NASDAQ:SYRS) Earns Buy Rating from HC Wainwright

    المصدر: Buzz FX / 01 نوفمبر 2024 08:46:15   America/New_York


    Syros Pharmaceuticals (NASDAQ:SYRS) Earns Buy Rating from HC Wainwright Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Syros Pharmaceuticals ( NASDAQ:SYRS - Get Free Report ) 's stock had its "buy" rating reiterated
    Read more...
شارك على،